Health
Study reveals new mutations that make cancer resistant to KRAS-targeted therapies – News-Medical.Net
A gene called KRAS is one of the most commonly mutated genes in all human cancers, and targeted drugs that inhibit the protein expressed by mutated KRAS have shown…
A gene called KRAS is one of the most commonly mutated genes in all human cancers, and targeted drugs that inhibit the protein expressed by mutated KRAS have shown promising results in clinical trials, with potential approvals by the U.S. Food and Drug Administration anticipated later this year.
Unfortunately, cancer cells often develop additional mutations that make them resistant to such targeted drugs, resulting in disease relapse. Now researchers led by a team at Massachusetts General Hospital…
-
General20 hours agoVideo allegedly showing man trying to catch freshwater crocodile prompts investigation
-
General22 hours agoLions on the brink with Eric Hipwood and Lachie Neale set to miss rest of premiership defence
-
General22 hours agoIsrael Defense Forces announce humanitarian area in Khan Younis
-
General21 hours agoBrotherly bond key to Birdsville Races epic journey